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under the CC BY-NC-ND license (http:Abstract Chronic alcohol use and gallstones are the most frequent causes of acute pancre-
atitis (AP), a life-threatening medical emergency. Above-normal calcium levels in these pa-
tients indicate potential malignancy or hyperparathyroidism (HPT). Whereas primary HPT
has been associated with AP, tertiary HPT has seldom been linked with AP. Herein we present
a case of peritoneal dialysis presenting with recurrent AP and incidental pancreatic duct calci-
fication due to tertiary HPT.
急性胰炎是致命的緊急疾病,最常見的病因為長期飲酒及膽結石。當這些病人的血鈣過高,意味著
癌症或副甲狀腺功能亢進的可能性。急性胰炎可能與原發性副甲狀腺功能亢進有關,但鮮少見於
三發性副甲狀腺功能亢進患者。以下是一宗三發性副甲狀腺功能亢進所致復發性急性胰炎的個
案,患者為腹膜透析接受者,並以偶發性胰管鈣化呈現。rmed Forces General Hospital, Number 2, Zhongzheng 1st Road, Lingya District, Kaohsiung City 802,
(M.-K. Tsai).
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Table 1 Laboratory parameters during acute pancreatitis
attack.
First Second Third This
admission
Months after 4 y of PD 29 38 42 43
Calcium (8.4e10.2
mg/dL)
10.7 10.2 10.6 10.4
Phosphate (2.4e4.5
mg/dL)
4.3 6.0 6.6 6.1
Parathyroid hormone
(3.4e7 mg/dL)
794.5 835 1324.3 1298.8
Serum amylase (29
e103 U/L)
61 21 195 140
Serum lipase (11e82
U/L)
1630 905 2585 1872
Peritoneal amylase (U/L) N/A N/A N/A 1
Peritoneal lipase (U/L) N/A N/A N/A 18
Peritoneal white blood
cell count
(<100 cells/mm3)
8 5 N/A 5
Peritoneal culture No
growth
N/A N/A No
growth
Alkaline phosphatase
(34e104 U/L)
105 168 164 144
Triglyceride (<150
mg/dL)
124 141 97 136
BUN (7e20 mg/dL) 46 72 69 46
Creatinine (0.7e1.2
mg/dL)
9.4 9.7 10.6 11.1
BUNZ blood urea nitrogen; N/AZ none available; PDZ per-
itoneal dialysis.
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Acute pancreatitis (AP) is a medical emergency; chronic
alcohol use and gallstones are the most common etiologies,
accounting for 60e70% of AP cases. Hypercalcemia result-
ing from a variety of conditions, including malignancy in the
setting of bone metastases or multiple myeloma, vitamin D
toxicity, sarcoidosis, familial hypocalciuric hypercalcemia,
total parenteral nutrition, perioperative high-dose calcium
infusions during cardiopulmonary bypass, and hyperpara-
thyroidism (HPT), can also lead to AP. Specifically, HPT
usually presents with hypercalcemia and high parathyroid
hormone (PTH) levels; however, HPT-mediated hypercal-
cemia is not a commonly associated etiology of AP; it is
reported only in 1.5e7% of AP cases in different series.1 AP
is most commonly regarded as a complication of primary
HPT (PHPT) and is rarely reported in tertiary HPT patients.2
Studies to date, suggest that patients with end-stage renal
disease (ESRD) have an increased risk of developing AP,3
which may further be influenced by the dialysis method
used, including peritoneal dialysis (PD).4 A number of
studies have reported an increase in the incidence of AP in
PD patients compared with those undergoing hemodialy-
sis4,5; however, the underlying mechanism is yet to be
established. Pancreatic calcification is an occasional
feature of chronic alcoholic pancreatitis and is a rarely
reported epiphenomenon in patients with tertiary HPT.
Here we report a patient with recurrent AP and tertiary HPT
in whom imaging studies revealed pancreatic calcifications.
Our findings will aid clinicians in achieving a better under-
standing of the underlying pathogenesis.
Case Report
A 60-year-old male with a history of hypertension and ESRD
presented to the emergency department with profound
epigastric pain radiating to the back; this pain was aggra-
vated on sitting up and while drinking water. Eight years
ago, the patient had been admitted to the hospital with
complaints of fever, fatigue, and bruising in the extremities
for 2 weeks. At that time, abdominal ultrasonography was
performed, which revealed the right kidney size to be
8.0 cm and the left kidney size to be 7.4 cm. Based on a
positive blood culture for Salmonella group D1, the patient
was tentatively diagnosed with Salmonella group D1
bacteremia and probable hypertension-related Stage IV
acute-on-chronic kidney injury; however, the patient had
denied renal biopsy. Although bacteremia improved with 10
days of intravenous ciprofloxacin treatment, due to the
progression of uremia, temporary hemodialysis was
needed. Since then, the patient had been on regular
continuous ambulatory PD with 4000 mL of 1.5% dextrose
solution and 4000 mL of 2.5% dextrose solution every day
for the last 8 years.
The patient did not have any previous complications due
to PD such as infectious peritonitis. However, he had
experienced three AP attacks in the last 2 years (Table 1).
His medication consisted of a maintenance therapy for the
prevention of renal osteodystrophy for the past 4 years with
0.5 g calcitriol (activated vitamin D) once a day, 400 g
magnesium aluminum silicate two times a day as aphosphate binder, and 1.0 g peptidine [consisted of
aluminum magnesium hydrate (400 mg) and magnesium
trisilicate (300 mg)] three times a day also as a phosphate
binder. He was an ex-smoker and denied alcohol abuse and
a family history of AP. The patient’s weight, height, and
body mass index (BMI) were 53 kg, 169 cm, and 18.5 kg/m2,
respectively. On admission, his temperature was 36.4C,
pulse rate was 78 bpm, and blood pressure was 210/
104 mmHg. Abdominal examination revealed moderate
distension with generalized tenderness on palpation, but
not on rebound, and auscultation revealed hypoactive
bowel sounds. He was empirically treated with cefoxitin
(1.0 g), intravenously administered every 8 hours, with an
initial diagnosis of AP and suspected infectious peritonitis.
Dialysate effluent fluid analysis showed a white blood cell
count of 5/L, and microbiology culture revealed no growth,
thus excluding the possibility of peritonitis. Despite anti-
biotic therapy for 5 days, his epigastric pain persisted, and
the patient failed to improve; thus, he was diagnosed with
AP based on the clinical presentation and laboratory find-
ings. Abdominal computed tomography (CT) done to
investigate recurrent AP revealed inflammation of the
pancreas, fat stranding with moderate free intra-abdominal
fluid, and no evidence of cholelithiasis. Satellite calcifica-
tions over the pancreatic body and duct, splenic artery, and
abdominal aorta were noted; no other metastatic calcifi-
cation sites were observed. (Figures 1A and 1B). Treatment
Figure 1 (A) Abdominal computed tomography (CT) showing satellite calcifications in the pancreas, splenic artery, and
abdominal aorta. (B) Calcified pancreatic duct in this section of abdominal CT is shown. (C) No obvious calcifications were observed
in the earlier abdominal CT performed 14 months before. (D) Serial serum calcium and phosphate levels after initiation and after
discontinuation of calcitriol treatment. PDZ peritoneal dialysis.
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nous fluids and analgesics. The patient did not have any
known common risk factors including history of alcohol
abuse, biliary tract abnormality, autoimmune disorders,
metabolic abnormalities such as hypertriglyceridemia, or
trauma, and was not on any medication that was known to
increase the risk of AP, such as steroids. Of note, a prior
abdominal CT performed 14 months ago during the first AP
episode did not detect any calcifications (Figure 1C), but
was notable for massive ascites and bilateral renal atrophy
with renal cysts of various sizes.
Despite initially lowering the dose of calcitriol from 0.5 g
to 0.125 g once a day, which was later discontinued for 3
weeks, hypercalcemia continued to persist and suggested
an underlying hypercalcemic disorder as the potential AP
etiology. The serum intact PTH (iPTH) level was 1298.8 pg/
mL (normal range: 15e88 pg/mL). Parathyroid ultrasonog-
raphy showed a lobulated hypoechoic nodule in the right
parathyroid gland, measuring 2.35 cm 1.39 cm 3.63 cm.
These findings were compatible with parathyroid adenoma
and hyperplasia; thus, the diagnosis was hypercalcemia dueto tertiary HPT. He was continued on maintenance therapy
with activated vitamin D, magnesium aluminum silicate,
and peptidine. Cinacalcet, to lower serum calcium and
PTH, was not available in our hospital, and the patient
refused parathyroidectomy despite medical advice. A
treatment plan that included a change of dialysis from AP
to hemodialysis and parathyroidectomy for prevention of
hypercalcemia-related recurrent AP was suggested; how-
ever, the patient declined due to personal reasons, and was
followed up at as an outpatient after an otherwise un-
eventful hospital stay.Discussion
Diagnosis of AP in continuous ambulatory PD is challenging
because amylase and lipase levels fluctuate due to renal
insufficiency. A rise in amylase levels three times above the
upper normal limit accompanied by acute onset of
abdominal pain defines AP. However, PD patients who use
the glucose polymer icodextrin as the osmotic agent have
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normal amylase levels.6 By contrast, determination of
serum lipase activity does not appear to be influenced by
the presence of icodextrin, and therefore may be an
effective method for diagnosing AP. Although our patient
used 1.5% dextrose solution (4000 mL) and 2.5% dextrose
solution (4000 mL) as the dialysate, we propose that the
normal amylase levels observed in the first two AP episodes
may be due to malnutrition, given his BMI of 18.5 kg/m2.7 As
AP presentation can be nonspecific and amylase levels can
be unreliable, many AP cases require imaging for diagnostic
confirmation. In our patient, the clinical presentation and
abdominal CT confirmed the AP diagnosis with the exclusion
of infectious peritonitis.
Renal insufficiency in dialysis patients predisposes them
to metabolic perturbations such as hypercalcemia and HPT,
both of which can cause AP.3 The first AP episode in our
patient likely resulted from hypercalcemia as depicted in
Figure 1D, based on the lack of calcifications in his initial
abdominal CT performed 14 months before the latest
episode (Figure 1C). The present CT scan of the abdomen in
our patient revealed multiple calcification on the pancreas
and pancreatic duct, splenic artery, and abdomen aorta.
After chronic alcoholic pancreatitis, HPT is the second most
likely etiology of pancreatic calcification. Chronic kidney
disease-related secondary HPT often leads to vascular cal-
cifications and calcium depositions in the soft tissue.8 We
propose that the pancreatic calcification in our patient was
related to the chronic secondary and tertiary HPT, which
resulted in inadequate removal of calcium and phosphate
and subsequent metastatic calcification. Our patient
developed hypercalcemia with elevated iPTH levels despite
calcitriol treatment for the past 4 years, which supported
the diagnosis of tertiary HPT. Hypercalcemia and recurrent
AP in our patient despite discontinuation of calcitriol for a
limited time excluded the possibility of calcitriol-mediated
AP.9 In addition, as seen in Figure 1D, parathyroid adenoma
and hyperplasia detected by ultrasonography confirmed the
clinical diagnosis.
Hypercalcemia, regardless of thecause,has beenshownto
lead to AP.10 Although all patients with chronic renal failure
have substantial secondary HPT, the number of reported
pancreatitis cases was minimal in these patients compared
with the PHPT group2e5; one reason may be the lower serum
calcium levels generally observed in patients with renal fail-
ure. As reflected by the Ranson grading of acute nonalcoholic
pancreatitis, severe AP is associatedwith a decrease in serum
calcium levels; however, increased serum calcium in the
context of AP may be a diagnostic clue to tertiary HPT. The
calcium values in PHPT range between 10 mg/dL and 12 mg/
dL,11 and this range was also observed in our patient.
Hypercalcemia may lead to AP via three pathophysio-
logical mechanisms. First, formation of calcium deposits in
the pancreatic duct can lead to the obstruction of the duct.
Second, the de novo activation of trypsinogen to trypsin can
result in acinar cell damage, autodigestion of the pancreas,
and subsequent pancreatitis.11 Finally, the association of
hypercalcemia may result from genetic variants of serine
protease inhibitor Kazal Type 1, cystic fibrosis trans-
membrane conductance regulator, or calcium-sensing re-
ceptor; these have been shown to increase the risk of AP in
PHPT patients.1,12Hypercalcemia in our patient was not likely a major
contributing factor for recurrent AP as hypercalcemia was
not found in all AP episodes. Thus, we propose that tertiary
HPT was a contributing factor to the vicious metastatic
calcification cycle. The metastatic calcification in the
pancreatic duct has been shown to modify pancreatic se-
cretions to cause protein plug and pancreatic calculi for-
mation.13 Pancreatic duct calcification, with disrupted
pancreatic enzyme transport and resultant ductal obstruc-
tion, can lead to subsequent attacks of acute or chronic
pancreatitis.13
AP predisposes patients to hypocalcemia and secondary
HPT; in our patient, chronic renal insufficiency contributed
to secondary HPT that was exacerbated by recurrent AP
episodes, leading to tertiary HPT. It is uncommon to detect
hypercalcemia in continuous ambulatory PD patients pre-
senting with severe AP; thus, its detection should always
alert physicians to the presence of HPT or malignancy.14 In
addition, AP due to tertiary HPT is uncommon, and clini-
cians should have a high level of suspicion in PD patients
with recurrent AP in the presence of elevated calcium and
PTH levels. Once the diagnosis is established, serial moni-
toring of serum calcium levels and iPTH with para-
thyroidectomy is necessary for prevention of recurrence.10
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